Click here to jump to the main content
National Drug Policy New Zealand Home.

National Drug Policy New Zealand

 
Print this   Email this

Publications


The benzylpiperazine (BZP) / trifluoromethylphenylpiperazine (TFMPP) and alcohol safety study

 Date of publication online: June 2008

An estimated 20 million doses of these party pills have been sold legally in New Zealand over the past six years. There is a significant gap in the research on the clinical effects of BZP and TFMPP, with only two small clinical trials on BZP published in the 1970s, and no clinical trials on TFMPP. This situation led to the Expert Advisory Committee on Drugs (EACD) recommendation that more information on the effects of BZP and TFMPP should be obtained.

Document availability


This publication is available in PDF format below:

The benzylpiperazine (BZP) / trifluoromethylphenylpiperazine (TFMPP) and alcohol safety study (PDF, 551 KB)

Page last updated: 30 June 2008



Legal | newzealand.govt.nz | Minister of Health